|
VeriChip Corporation Announces
Changes to Board of Directors to Remove all Overlap with Digital
Angel
DELRAY BEACH, FL – January
16, 2008 –VeriChip Corporation (NASDAQ: CHIP), a provider of RFID
systems for healthcare and patient-related needs, today announced a
series of changes to its Board of Directors to remove all overlap
between its Board and Digital Angel’s Board. Constance K. Weaver and
Daniel E. Penni, who serve on the Digital Angel Board, have stepped
down from the VeriChip Board, and Barry M. Edelstein, has stepped
down from the Digital Angel Board and joined the VeriChip Board.
These changes create two independent Boards of Directors with no
common Board members.
About VeriChip
VeriChip Corporation, headquartered in
Delray Beach, Florida, develops, markets and sells radio frequency
identification, or RFID, systems used to identify, locate and
protect people and assets. VeriChip's goal is to become the leading
provider of RFID systems for people in the healthcare industry. The
Company recently began marketing its VeriMed(TM) Patient
Identification System, a passive RFID system for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, the implantable VeriChip(TM),
cleared for medical use in October 2004 by the United States Food
and Drug Administration.
For more information on VeriChip, please
call 1-800-970-2447, or email info@verichipcorp.com. Additional
information can be found online at
http://www.verichipcorp.com.
Statements about the Company's future expectations, including future
revenues and earnings, and all other statements in this press
release other than historical facts are "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934, and as that term
is defined in the Private Litigation Reform Act of 1995. Such
forward-looking statements involve risks and uncertainties and are
subject to change at any time, and the Company's actual results
could differ materially from expected results. The Company
undertakes no obligation to update forward-looking statements to
reflect subsequently occurring events or circumstances.
###
CONTACTS:
Dan Schustack
CEOcast
212-732-4300
dschustack@ceocast.com
Allison Tomek
VeriChip
Corporation
(561) 805-8008
atomek@adsx.com
Back
|
